Filing Details
- Accession Number:
- 0001628280-23-003922
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-16 16:54:03
- Reporting Period:
- 2023-02-14
- Accepted Time:
- 2023-02-16 16:54:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1933414 | Mineralys Therapeutics Inc. | MLYS | () | E9 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1746274 | Catalys Pacific Fund, Lp | Po Box 309, Ugland House, Cayman Islands Grand Cayman E9 KY1-1104 | No | No | Yes | No | |
1963901 | Taylor Brian Slingsby | Shoto City House 203, 1-23-3, Shoto, Shibuya-Ku M0 150-0046 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-02-14 | 4,314,093 | $0.00 | 8,944,579 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2023-02-14 | 250,000 | $16.00 | 9,194,579 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2023-02-14 | 2,171,342 | $0.00 | 2,171,342 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2023-02-14 | 2,142,751 | $0.00 | 2,142,751 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering.
- Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, the general partner of the General Partner. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.